Systems-based hematology: highlighting successes and next steps
Abstract. Systems-based hematology is dedicated to improving care delivery for patients with blood disorders. First defined by the American Society of Hematolog
Abstract. Systems-based hematology is dedicated to improving care delivery for patients with blood disorders. First defined by the American Society of Hematolog
Should we integrate business literacy into medical training to better equip future physicians for the demands of their careers and personal lives?
Monday, May 6, 2024, 5:00 PM – 6:00 PM Eastern Time Register for this complimentary event with the “Register Now” button above, which will take…
Key Points. Obinutuzumab can safely be used in combination with chemotherapy and in maintenance after ASCT as frontline therapy in MCL patients.Obinutuzuma
Adding ibrutinib to first-line treatment resulted in superior efficacy in younger mantle cell lymphoma patients with increased toxicity when given after ASCT. Adding ibrutinib during…
Abstract. The routine use of next-generation sequencing methods has underscored the genetic and clonal heterogeneity of acute myeloid leukemia (AML), subsequent
Abstract. Treatment options for acute myeloid leukemia (AML) have expanded over the last 5 years. New regimens are increasing the options for patients who
Abstract. Intensive chemotherapy in combination with allogeneic hematopoietic cell transplantation and supportive care can induce long-term remissions in a
Key Points. High-dose alemtuzumab led to effective suppression of chronic GVHD.Lymphodepletion delays Tn recovery resulting in lower TCR repertoire and hig
Gulrayz Ahmed, Aseel Alsouqi, Aniko Szabo, Laura Samples, Mazyar Shadman, Farrukh T Awan, Alexandra E. Rojek, Peter A Riedell, Madiha Iqbal, Timothy S. Fen
In this issue of Blood, Fuchs et al1 have used T-cell biology, coupled with Genome Wide Association Studies (GWAS) and computational leverage of public dat